Efficacy and Acceptability of Two Lubricant Eye Drops

Allergan

Status and phase: Completed; Phase 4

Conditions: Dry Eye Syndromes

Treatments: Drug: Lubricating Eye Drops (blink® Tears); Drug: Lubricant Eye Drops (Optive™)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00756678

MA-OPT-08-001

Details and patient eligibility

About

Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.

Enrollment: 51 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male or Female
• At least 18 years of age
• Current use of artificial tears

Exclusion criteria

• Any uncontrolled systemic disease
• Pregnancy or planning a pregnancy
• Contact lens wear

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

51 participants in 2 patient groups

1

Active Comparator group

Description:

Carboxymethylcellulose and Glycerin

Treatment:

Drug: Lubricant Eye Drops (Optive™)

2

Active Comparator group

Description:

Polyethylene glycol 400

Treatment:

Drug: Lubricating Eye Drops (blink® Tears)